Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC).
Gonzales NR, Shah J, Sangha N, Sosa L, Martinez R, Shen L, Kasam M, Morales MM, Hossain MM, Barreto AD, Savitz SI, Lopez G, Misra V, Wu TC, El Khoury R, Sarraj A, Sahota P, Hicks W, Acosta I, Sline MR, Rahbar MH, Zhao X, Aronowski J, Grotta JC.
Gonzales NR, et al. Among authors: barreto ad.
Int J Stroke. 2013 Jul;8(5):388-96. doi: 10.1111/j.1747-4949.2011.00761.x. Epub 2012 Feb 20.
Int J Stroke. 2013.
PMID: 22340518
Clinical Trial.